The Eurocrats are getting ready to vote on a proposal to introduce something that looks remarkably like PMA for higher risk implantable devices. Industry representatives have picked up a few flaws in the argument supporting this regulatory sea-change, and we’re inclined to agree.
Read all about it here in our weekly View From The Med, which will also be available as a podcast on Monday.
published: June 28, 2013 in: medlatest Editorial, Regulatory